[Clinical Value of 18 F-FDG PET/CT for Patients with B Cell Lymphoma-Associated Hemophagocytic Syndrome].

MLA

Ding, Chong-Yang, et al. “[Clinical Value of 18 F-FDG PET/CT for Patients with B Cell Lymphoma-Associated Hemophagocytic Syndrome].” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 25, no. 1, Feb. 2017, pp. 133–37. EBSCOhost, https://doi.org/10.7534/j.issn.1009-2137.2017.01.023.

APA

Ding, C.-Y., Liu, H.-Y., Guo, Z., Li, Y.-Y., Yang, W.-P., & Li, T.-N. (2017). [Clinical Value of 18 F-FDG PET/CT for Patients with B Cell Lymphoma-Associated Hemophagocytic Syndrome]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 25(1), 133–137. https://doi.org/10.7534/j.issn.1009-2137.2017.01.023

Chicago

Ding, Chong-Yang, Hong-Yu Liu, Zhe Guo, Yang-Yang Li, Wen-Ping Yang, and Tian-Nv Li. 2017. “[Clinical Value of 18 F-FDG PET/CT for Patients with B Cell Lymphoma-Associated Hemophagocytic Syndrome].” Zhongguo Shi Yan Xue Ye Xue Za Zhi 25 (1): 133–37. doi:10.7534/j.issn.1009-2137.2017.01.023.